Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective studyJiangtao Cheng, Jin‐Ji Yang, Yu-Er Gao et al.|Lung Cancer|2020Cited by 9